BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 31764017)

  • 1. Clinical Outcomes of Patients With Unresectable Cholangiocarcinoma Treated With Proton Beam Therapy.
    Hung SP; Huang BS; Hsieh CE; Lee CH; Tsang NM; Chang JT; Chen JS; Chou WC; Tseng JH; Hong JH
    Am J Clin Oncol; 2020 Mar; 43(3):180-186. PubMed ID: 31764017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcomes and toxicity of proton beam therapy for advanced cholangiocarcinoma.
    Makita C; Nakamura T; Takada A; Takayama K; Suzuki M; Ishikawa Y; Azami Y; Kato T; Tsukiyama I; Kikuchi Y; Hareyama M; Murakami M; Fuwa N; Hata M; Inoue T
    Radiat Oncol; 2014 Jan; 9():26. PubMed ID: 24422711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcomes of previously untreated patients with unresectable intrahepatic cholangiocarcinoma following proton beam therapy.
    Shimizu S; Okumura T; Oshiro Y; Fukumitsu N; Fukuda K; Ishige K; Hasegawa N; Numajiri H; Murofushi K; Ohnishi K; Mizumoto M; Nonaka T; Ishikawa H; Sakurai H
    Radiat Oncol; 2019 Dec; 14(1):241. PubMed ID: 31881895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton beam therapy for unresectable intrahepatic cholangiocarcinoma.
    Ohkawa A; Mizumoto M; Ishikawa H; Abei M; Fukuda K; Hashimoto T; Sakae T; Tsuboi K; Okumura T; Sakurai H
    J Gastroenterol Hepatol; 2015 May; 30(5):957-63. PubMed ID: 25376272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypofractionated Radiation Therapy for Unresectable/Locally Recurrent Intrahepatic Cholangiocarcinoma.
    Smart AC; Goyal L; Horick N; Petkovska N; Zhu AX; Ferrone CR; Tanabe KK; Allen JN; Drapek LC; Qadan M; Murphy JE; Eyler CE; Ryan DP; Hong TS; Wo JY
    Ann Surg Oncol; 2020 Apr; 27(4):1122-1129. PubMed ID: 31873931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Consideration of the role of radiotherapy for unresectable intrahepatic cholangiocarcinoma: a retrospective analysis of 75 patients.
    Zeng ZC; Tang ZY; Fan J; Zhou J; Qin LX; Ye SL; Sun HC; Wang BL; Li D; Wang JH; Zeng MS; Guo W; Tan YS
    Cancer J; 2006; 12(2):113-22. PubMed ID: 16630402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limitations of conventional doses of chemoradiation for unresectable biliary cancer.
    Crane CH; Macdonald KO; Vauthey JN; Yehuda P; Brown T; Curley S; Wong A; Delclos M; Charnsangavej C; Janjan NA
    Int J Radiat Oncol Biol Phys; 2002 Jul; 53(4):969-74. PubMed ID: 12095564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton Beam Radiotherapy and Concurrent Chemotherapy for Unresectable Stage III Non-Small Cell Lung Cancer: Final Results of a Phase 2 Study.
    Chang JY; Verma V; Li M; Zhang W; Komaki R; Lu C; Allen PK; Liao Z; Welsh J; Lin SH; Gomez D; Jeter M; O'Reilly M; Zhu RX; Zhang X; Li H; Mohan R; Heymach JV; Vaporciyan AA; Hahn S; Cox JD
    JAMA Oncol; 2017 Aug; 3(8):e172032. PubMed ID: 28727865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.
    Hong TS; Wo JY; Yeap BY; Ben-Josef E; McDonnell EI; Blaszkowsky LS; Kwak EL; Allen JN; Clark JW; Goyal L; Murphy JE; Javle MM; Wolfgang JA; Drapek LC; Arellano RS; Mamon HJ; Mullen JT; Yoon SS; Tanabe KK; Ferrone CR; Ryan DP; DeLaney TF; Crane CH; Zhu AX
    J Clin Oncol; 2016 Feb; 34(5):460-8. PubMed ID: 26668346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective feasibility study of respiratory-gated proton beam therapy for liver tumors.
    Hong TS; DeLaney TF; Mamon HJ; Willett CG; Yeap BY; Niemierko A; Wolfgang JA; Lu HM; Adams J; Weyman EA; Arellano RS; Blaszkowsky LS; Allen JN; Tanabe KK; Ryan DP; Zhu AX
    Pract Radiat Oncol; 2014; 4(5):316-322. PubMed ID: 25194100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chest wall toxicity after hypofractionated proton beam therapy for liver malignancies.
    Yeung R; Bowen SR; Chapman TR; MacLennan GT; Apisarnthanarax S
    Pract Radiat Oncol; 2018; 8(4):287-293. PubMed ID: 29452863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereotactic body radiotherapy (SBRT) for locally advanced intrahepatic and extrahepatic cholangiocarcinoma.
    Gkika E; Hallauer L; Kirste S; Adebahr S; Bartl N; Neeff HP; Fritsch R; Brass V; Nestle U; Grosu AL; Brunner TB
    BMC Cancer; 2017 Nov; 17(1):781. PubMed ID: 29162055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereotactic body radiotherapy in the management of oligometastatic and recurrent biliary tract cancer: single-institution analysis of outcome and toxicity.
    Franzese C; Bonu ML; Comito T; Clerici E; Loi M; Navarria P; Franceschini D; Pressiani T; Rimassa L; Scorsetti M
    J Cancer Res Clin Oncol; 2020 Sep; 146(9):2289-2297. PubMed ID: 32524292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salvage radiation therapy for isolated local recurrence of extrahepatic cholangiocarcinoma after radical surgery: a retrospective study.
    Kim SW; Lim DH; Park HC; Park W; Park JO; Park YS
    Ann Surg Oncol; 2015 Apr; 22(4):1308-14. PubMed ID: 25319582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment Selection and Survival Outcomes With and Without Radiation for Unresectable, Localized Intrahepatic Cholangiocarcinoma.
    Jackson MW; Amini A; Jones BL; Rusthoven CG; Schefter TE; Goodman KA
    Cancer J; 2016; 22(4):237-42. PubMed ID: 27441741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypofractionated Radiation Therapy: A Potential Option for Advanced Intrahepatic Cholangiocarcinoma.
    Shindoh J
    Ann Surg Oncol; 2020 Apr; 27(4):983-984. PubMed ID: 31848809
    [No Abstract]   [Full Text] [Related]  

  • 17. Proton Beam Therapy in Liver Malignancies.
    Siddiqui O; Pollock A; Samanta S; Kaiser A; Molitoris JK
    Curr Oncol Rep; 2020 Feb; 22(3):30. PubMed ID: 32108284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative toxicity outcomes of proton-beam therapy versus intensity-modulated radiotherapy for prostate cancer in the postoperative setting.
    Santos PMG; Barsky AR; Hwang WT; Deville C; Wang X; Both S; Bekelman JE; Christodouleas JP; Vapiwala N
    Cancer; 2019 Dec; 125(23):4278-4293. PubMed ID: 31503338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival outcomes in resected extrahepatic cholangiocarcinoma: effect of adjuvant radiotherapy in a surveillance, epidemiology, and end results analysis.
    Vern-Gross TZ; Shivnani AT; Chen K; Lee CM; Tward JD; MacDonald OK; Crane CH; Talamonti MS; Munoz LL; Small W
    Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):189-98. PubMed ID: 20971573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of radiotherapy in the management of locally advanced extrahepatic cholangiocarcinoma.
    Moureau-Zabotto L; Turrini O; Resbeut M; Raoul JL; Giovannini M; Poizat F; Piana G; Delpero JR; Bertucci F
    BMC Cancer; 2013 Dec; 13():568. PubMed ID: 24299517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.